NeoGenomics NEO EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about NeoGenomics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NeoGenomics's EBITDA?
- NeoGenomics (NEO) reported EBITDA of -$1.83M in Q1 2026.
- How has NeoGenomics's EBITDA changed year-over-year?
- NeoGenomics's EBITDA increased by 81.9% year-over-year, from -$10.1M to -$1.83M.
- What is the long-term trend for NeoGenomics's EBITDA?
- Over 4 years (2021 to 2025), NeoGenomics's EBITDA has grown at a -7.4% compound annual growth rate (CAGR), from -$65.4M to -$48.06M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.